ELI LILLY & Co·4

Feb 11, 6:22 PM ET

Norton Johna 4

4 · ELI LILLY & Co · Filed Feb 11, 2022

Insider Transaction Report

Form 4
Period: 2022-02-09
Norton Johna
Senior VP, Global Quality
Transactions
  • Award

    Common Stock

    2022-02-09$243.27/sh+3,294$801,33130,240 total
  • Award

    Restricted Stock Unit

    2022-02-09+2,1022,102 total
    From: 2023-02-01Exp: 2023-02-01Common Stock (2,102 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    514
  • Common Stock

    (indirect: by partner)
    128
  • Common Stock

    (indirect: By 401(k))
    2,675
Footnotes (2)
  • [F1]Reporting person disclaims beneficial ownership of these shares.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Documents

1 file
  • 4
    wf-form4_164462174983605.xmlPrimary

    FORM 4